Infectious disease doctors test your blood or other body fluids to look for specific antibodies — cells produced by our immune system to fight harmful foreign substances. These tests can indicate what kind of infection is present. For bacterial infections, treatment usually involves antibiotics. Launch of mobile & self-testing devices has increased access to testing and monitoring systems to the remote places where the provision of timely medical care is a challenge.
This report contains market size and forecasts of Point of Care Infectious Disease Testing in Global, including the following market information:
Global Point of Care Infectious Disease Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Point of Care Infectious Disease Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
HIV POC Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Point of Care Infectious Disease Testing include Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers, BD, Chembio Diagnostics, Trinity Biotech, Cardinal Health and Quest Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Point of Care Infectious Disease Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Point of Care Infectious Disease Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Point of Care Infectious Disease Testing Market Segment Percentages, by Type, 2021 (%)
HIV POC
HBV POC
Pneumonia or Streptococcus Associated Infections
Respiratory Syncytial Virus (RSV) POC
HPV POC
Influenza POC
Others
Global Point of Care Infectious Disease Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Point of Care Infectious Disease Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Home
Others
Global Point of Care Infectious Disease Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Point of Care Infectious Disease Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Point of Care Infectious Disease Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Point of Care Infectious Disease Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alere
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens Healthineers
BD
Chembio Diagnostics
Trinity Biotech
Cardinal Health
Quest Diagnostics
Bio-Rad Labs
bioMérieux
Sight Diagnostics
Gene POC
Trivitron Healthcare
OJ-Bio
Ortho-Clinical Diagnostics